Literature DB >> 240701

Uptake of taurocholic acid into isolated rat-liver cells.

L R Schwarz, R Burr, M Schwenk, E Pfaff, H Greim.   

Abstract

Binding and transport characteristics for uptake of taurocholic acid by isolated rat liver cells were studied. 1. An adsorption of taurocholate to the cell surface is terminated in less than 15 s. A Ks of 0.55 mM and a total binding capacity of 3.8 nmol/mg cell protein is determined. 2. The rate of uptake of taurocholate follows Michaelis-Menten kinetics with Km = 19 muM and V = 1.7 nmol/mg protein min. 3. There is a broad pH optimum for uptake between pH 6.5 -- 8.0. 4. The activation energy amounts to 29 kcal/mol. At high taurocholate concentration an unusual upward bend is observed in the Arrhenius plot. 5. Taurocholate uptake is competitively inhibited by taurochenodeoxycholate (Ki = 9 muM). It is noncompetitively inhibited by bromosulfophthalein (Ki = 3 muM). 6. At physiological taurocholate concentrations a 200-fold intracellular accumulation of taurocholate is observed. 7. Uptake is inhibited by about 75% by either antimycin A, carbonylcyanide m-chlorophenyl-hydrazone, ouabain. 8. Replacement of extracellular Na+ by either K+ or sucrose results in a 75% decrease of uptake. 9. It is concluded that taurocholate uptake is a carrier-mediated process, and suggested that the energy for intracellular accumulation is made available by cotransport of Na+.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240701     DOI: 10.1111/j.1432-1033.1975.tb02199.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  59 in total

1.  Kinetic analysis of the dose-dependent hepatic handling of 1-anilino-8-naphthalene sulfonate in rats.

Authors:  Y B Chung; S Miyauchi; Y Sugiyama; H Harashima; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

2.  Influence of viability on bromosulfophthalein uptake by isolated hepatocytes.

Authors:  M Schwenk; R Burr; E Pfaff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-10       Impact factor: 3.000

3.  The lack of active bile acid transport in AS-30 D ascites hepatoma cells.

Authors:  R Kroker; M S Anwer; D Hegner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-07       Impact factor: 3.000

4.  Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate.

Authors:  M S Roberts; S Fraser; A Wagner; L McLeod
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

5.  Properties of phallotoxin uptake by basolateral plasma membrane vesicles from rat liver: evidence for a carrier-mediated transport.

Authors:  M Täfler; K Ziegler; M Frimmer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

6.  Intrahepatic cholestasis as a side-effect of drug therapy.

Authors:  G Feuer; M S Dhami
Journal:  Can Fam Physician       Date:  1982-07       Impact factor: 3.275

Review 7.  Prediction of hepatic clearance in human from in vitro data for successful drug development.

Authors:  Masato Chiba; Yasuyuki Ishii; Yuichi Sugiyama
Journal:  AAPS J       Date:  2009-04-30       Impact factor: 4.009

8.  Ketoconazole blocks bile acid synthesis in hepatocyte monolayer cultures and in vivo in rat by inhibiting cholesterol 7 alpha-hydroxylase.

Authors:  H M Princen; C M Huijsmans; F Kuipers; R J Vonk; H J Kempen
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

9.  [Pathogenic significance of bile acids (author's transl)].

Authors:  W Gerok; S Matern
Journal:  Klin Wochenschr       Date:  1981-06-15

10.  Drug-induced intrahepatic cholestasis: characterization of different pathomechanisms.

Authors:  H Krell; J Metz; H Jaeschke; H Höke; E Pfaff
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.